Search results for "Granulosa"

showing 7 items of 17 documents

Nuclear localization of the protein encoded by the Wilms’ tumor gene WT1 in embryonic and adult tissues

1993

ABSTRACT The human Wilms’ tumor gene WT1 encodes a putative transcription factor implicated in tumorigenesis and in specifying normal urogenital development. We have studied the distribution of WT1 protein and mRNA using immunohistochemistry and in situ hybridization. Monoclonal antibodies were raised against a peptide specific to the first alternative splice site of WT1. Two antibodies specifically reacted on Western blot to this WT1 isoform. Immunofluorescence localized WT1 protein to podocytes during mesonephric and metanephric development. In situ hybridization revealed a similar pattern of expression except that WT1 mRNA was also present in metanephric blastema and renal vesicles. Mess…

MaleGene isoformcongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyBlotting WesternFluorescent Antibody TechniqueGene ExpressionUrogenital SystemIn situ hybridizationBiologyKidneyurologic and male genital diseasesPolymerase Chain ReactionInternal medicineGene expressionmedicineHumansRNA MessengerWT1 ProteinsMolecular BiologyTranscription factorIn Situ HybridizationCell NucleusMessenger RNAGranulosa CellsSertoli Cellsurogenital systemfungiZinc FingersWilms' tumormedicine.diseasefemale genital diseases and pregnancy complicationsWilms Tumor ProteinCell biologyDNA-Binding ProteinsCell nucleusmedicine.anatomical_structureEndocrinologyMesonephrosFemaleTranscription FactorsDevelopmental BiologyDevelopment
researchProduct

Inhibin-α, CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome

2000

We investigated 115 testicular and 3 epididymal tumors and 6 cases of the complete androgen insensitivity syndrome (AIS) for the expression of inhibin-alpha, CD99, HEA125, PLAP, and chromogranin, using monoclonal antibodies and standard immunhistochemical techniques. Ihibin-alpha was detected in the neoplastic cells in 27 of 27 primary Leydig cell tumors (LCTs), 1 of 1 metastatic LCT, 6 of 20 Sertoli cell tumors (SCTs), 4 of 5 juvenile granulosa cell tumors (GCTs), and 2 of 5 unclassified sex cord-stromal tumors (USCSTs). Except for 2 choriocarcinomas, the choriocarcinomatous component of 1 mixed germ cell tumor, and a small focus of inhibin-positive syncytiotrophoblast in 1 embryonal carci…

Maleendocrine systemmedicine.medical_specialtyPathologyendocrine system diseasesCD9912E7 AntigenBiologyPathology and Forensic MedicineEmbryonal carcinomaTesticular NeoplasmsAntigens CDAntigens NeoplasmRete testisInternal medicineBiomarkers TumorChromograninsmedicineHumansInhibinsRhabdomyosarcomaGranulosa Cell TumorEpididymisLeydig cellProteinsChromogranin AAndrogen-Insensitivity Syndromemedicine.diseaseSertoli cellNeoplasm Proteinsmedicine.anatomical_structureEndocrinologyFluorescent Antibody Technique DirectAntigens Surfacebiology.proteinGerm cell tumorsPeptidesCell Adhesion MoleculesHuman Pathology
researchProduct

Expression of Muscarinic Receptor Types in the Primate Ovary and Evidence for Nonneuronal Acetylcholine Synthesis1

2001

The presence of muscarinic receptors (MR) in the ovary of different species has been recognized, but the identity of these receptors as well as ovarian sources of their natural ligand, acetylcholine (ACh), have not been determined. Because luteinized human granulosa cells (GC) in culture express functional MR, we have determined whether the group of the related MR subtypes, M1R, M3R, and M5R, are present in vivo in human and rhesus monkey ovaries. To this end, ribonucleic acids (RNAs) of different human and monkey ovaries as well as RNAs from human GC and monkey oocytes were reverse transcribed and subjected to PCR amplification, followed by sequencing of the amplified complementary DNAs. R…

Messenger RNAmedicine.medical_specialtyEndocrinology Diabetes and MetabolismGranulosa cellBiochemistry (medical)Clinical BiochemistryOvaryBiologyBiochemistryCholine acetyltransferaseMolecular biologyEndocrinologymedicine.anatomical_structureEndocrinologyInternal medicineMuscarinic acetylcholine receptormedicineReceptorAcetylcholinemedicine.drugAcetylcholine receptorThe Journal of Clinical Endocrinology & Metabolism
researchProduct

APOPTOSIS RATE IN CUMULUS CELLS AS POSSIBLE MOLECULAR BIOMARKER FOR OOCYTE COMPETENCE.

2017

Several lines of evidence showed that apoptosis rate of cumulus cells in oocytes derived by assisted reproductive technologies could be used as an indicator of fertilizing gamete quality. Aim of the study was to investigate the effects of three different ovarian stimulation protocols on the biological and clinical outcome in hyporesponder patients. Collected data showed a higher significant rate of DNA fragmentation index (DFI) in U group (patients treated with Highly Purified human Menopausal Gonadotrophin) than in P group (treated with recombinant human Follicle Stimulating Hormone (r-hFSH) combined with recombinant human Luteinizing Hormone (r-hLH)). Both groups R (treated with r-hFSH al…

Oocyte competence Granulosa cells DNA fragmentation Hormonal treatment Poor responderSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct

Estudio del receptor 2 de la dopamina en ovario humano y efecto de su modulación sobre el Síndrome de Hiperestimulación Ovárica

2012

El síndrome de hiperestimulación ovárica (SHO) es una complicación iatrogénica derivada del uso de gonadotropinas exógenas para la inducción de la ovulación que cursa durante la fase lútea o el embarazo, pudiendo causar graves efectos sobre la salud e incluso la muerte. El uso de agonistas del receptor 2 de la dopamina (DrD2) se ha visto efectivo en el tratamiento de SHO, sin embargo tan solo se obtienen resultados beneficiosos en el 50% de los casos de SHO temprano, mientras que es totalmente inefectivo en los casos de SHO tardío. Para tratar de establecer los mecanismos moleculares que dan lugar a esta situación, se ha llevado a cabo una descripción a nivel histológico de la expresión del…

UNESCO::CIENCIAS MÉDICAS::Ciencias clínicas::GinecologíaUNESCO::CIENCIAS MÉDICAS::Medicina interna::Endocrinología:CIENCIAS MÉDICAS::Medicina interna::Endocrinología [UNESCO]:CIENCIAS DE LA VIDA::Fisiología humana::Fisiología de la reproducción [UNESCO]DopaminaGranulosaVEGFUNESCO::CIENCIAS DE LA VIDA::Fisiología humana::Fisiología de la reproducciónOvarioSHODrD2:CIENCIAS MÉDICAS::Farmacología::Evaluación de medicamentos [UNESCO]:CIENCIAS MÉDICAS::Ciencias clínicas::Ginecología [UNESCO]UNESCO::CIENCIAS MÉDICAS::Farmacología::Evaluación de medicamentos
researchProduct

Tumor de células de la granulosa extraovárico con mutación FOXL2. Diagnóstico diferencial morfológico e inmunohistoquímico

2020

Extraovarian granulosa cell tumor is a very uncommon tumor and the identification of a recurrent mutation in FOXL2 may be used as another diagnostic tool along with the classical morphological and immunohistochemical findings. Here, we report a new case of extraovarian granulosa cell tumor in a 57 years old female patient presented with a sub-hepatic mass and abdominal pain. Histopathological examination of the excised mass showed features of adult-type granulosa cell tumor with α-inhibin, calretinin, WT1, S100, CD99 and progesterone receptor immunoreactivity. A FOXL2 mutation was detected on molecular biology study. A final diagnosis was an extraovarian adult-type granulosa cell tumor. We …

endocrine systemPathologymedicine.medical_specialtyAbdominal painurogenital systemGranulosa cellCD99BiologyPathology and Forensic Medicine03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisFemale patientProgesterone receptormedicineImmunohistochemistry030211 gastroenterology & hepatologyDifferential diagnosisCalretininmedicine.symptomRevista Española de Patología
researchProduct

Análisis molecular de la valoración del intervalo de tiempo óptimo entre la administración de acetato de triptorelina y la punción folicular en los t…

2023

Los fármacos análogos de la GnRH y la hCG han demostrado ser igualmente eficaces en la activación de la cascada de intermediarios de la maduración final ovocitaria que ocurre tras el estímulo ovulatorio. Sin embargo, su mecanismo de acción y por tanto los perfiles hormonales hallados tras el estímulo de los dos fármacos son muy diferentes. El tiempo más adecuado para programar la recolección ovocitaria tras la administración de acetato de triptorelina podría no ser 36 horas como ampliamente se ha pautado en los tratamientos de FIV con hCG. Este intervalo de tiempo es sumamente importante para obtener la mayor proporción posible de ovocitos MII porque procesos como el inicio de la luteinizac…

lhfármacos análogos agonistas de la hormona liberadora de gonadotrofinaUNESCO::CIENCIAS DE LA VIDA::Biología humana ::Embriología humanafecundación in vitroampiregulinabetacelulinaphlda1UNESCO::QUÍMICA::Bioquímica ::Biología molecularprogesteronapcrtrigger 36hfisiología de la reproducción humana asistidaugp2marcadores moleculares no invasivos de madurez ovocitariahumanorgs2trigger 40htrigger 30hacetato de triptorelinaUNESCO::CIENCIAS MÉDICAS ::Farmacodinámica::Acción de los medicamentosepiregulinagnrhhormonasovocito metafase iiUNESCO::CIENCIAS DE LA VIDA::Fisiología humana ::Fisiología de la reproduccióncélulas de la granulosaelisalíquido folicularefnb2embriologíacyp19a1adamts9
researchProduct